Dr. SMITH SUTE

Dr. SRI GANESH, Dr. SHEETAL BRAR

Abstract

Purpose: To compare the long term clinical outcomes and patient satisfaction between the Eyecryl Toric P-IOL(ET PIOL) and Visian Toric ICL( T-ICL) V4c for the treatment of high myopic astigmatism.

Study design- Prospective, interventional, comparative study.

Methods: Fifty eyes from 50 patients (25 in each group) received ET PIOL or T-ICL. Both the groups were appropriately matched with respect to mean age, pre-op SE, cylinder, pre-op CDVA, and contrast sensitivity scores. Mean follow-up of 20.4 months.

Results: At 2 years, 72% T-ICL eye & 76% ET PIOL eyes had UDVA of 20/20 or better. 64% ET PIOL eyes in & 52% T-ICL gained one or more lines of CDVA and there was no loss of CDVA in both the groups.Both groups showed SE predictability ±0.5 D in 80% eyes. No complications were noted. The ECD, vault and IOP remained stable.

Conclusion: Both toric phakic IOLs showed good safety, efficacy, predictability and rotational stability in treating high myopic astigmatism.